Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Category: Guides

Viruses Structure

If you need a clear, evidence based explanation of what viruses are made of and how their components work together, this guide is for you. Viruses are not living cells. They are compact infectious particles built from a core of genetic material (DNA or RNA) surrounded by a protective protein shell called the capsid. Many viruses wrap themselves in an extra lipid envelope derived from host cell membranes. Understanding this structure is essential for researchers, bioinformaticians, and students who work with viral genomics, drug design, or diagnostic development. The NCBI Bookshelf offers authoritative textbook chapters on viral architecture, including classification by capsid symmetry and genome type NCBI Bookshelf. Whether you are analyzing viral sequences from a public database or modeling a capsid protein, this guide provides a practical framework grounded in current sources.

The study of virus structure has direct implications for vaccine design, antiviral therapy, and outbreak surveillance. For example, the arrangement of surface proteins determines how a virus binds to host cells, and the stability of the capsid influences how long a virus survives outside a host. Training resources from EMBL EBI cover methods to predict protein structures and visualize macromolecular complexes, which are directly applicable to viral structural biology EMBL-EBI Training. Below you will find a high level overview followed by decision criteria, a practical workflow, quality checks, common pitfalls, and limits of interpretation.

At a Glance

Component Description Key Features
Genetic material DNA or RNA, single or double stranded, linear or circular Determines replication strategy and evolutionary rate
Capsid Protein shell that encloses the genome Exhibits helical, icosahedral, or complex symmetry
Envelope (optional) Lipid bilayer derived from host cell Contains viral glycoproteins for host recognition
Tegument (in some large viruses) Protein layer between capsid and envelope Contains enzymes needed for early infection steps
Glycoproteins Spikes or peplomers on envelope surface Mediate entry into host cells and trigger immune response

Core Concepts

Genome Type and Organization

Every virus carries either DNA or RNA, never both. The genome can be single stranded (ss) or double stranded (ds), linear or circular, and may be segmented. This primary decision influences almost everything downstream: antiviral target selection, detection method, and evolutionary dynamics. The EMBL EBI training modules on viral bioinformatics emphasize that genome structure dictates the polarity of mRNA production and the need for viral polymerases EMBL-EBI Training.

Capsid Symmetry

Capsid architecture falls into three major symmetry classes:

  • Helical: Capsid proteins arrange in a continuous helix around the genome. Examples include tobacco mosaic virus and many negative sense RNA viruses.
  • Icosahedral: Capsid proteins form an approximately spherical shell with 20 triangular faces. Many human pathogens such as adenovirus and norovirus use this design.
  • Complex: Unique shapes seen in bacteriophages (with head tail morphology) and giant viruses. A recent study used integrative structural interactomics to map the elaborate protein organization inside a giant virus, revealing a layered internal structure that challenges simple classification Integrative structural interactomics reveals protein organization and structure in a giant virus.

Envelope and Glycoproteins

The presence or absence of an envelope is a major taxonomic marker. Enveloped viruses (e.g., influenza, HIV, SARS CoV 2) are generally more sensitive to environmental conditions like heat and detergents. Non enveloped viruses (e.g., rotavirus, rhinovirus) are more stable and can persist on surfaces. The envelope itself does not contain any metabolic enzymes, it simply carries viral glycoproteins that mediate attachment and fusion.

Decision Criteria for Analyzing Virus Structure

When you encounter an unknown virus sequence or isolate, consider the following steps:

  1. Identify the genome type. Use BLAST or a taxonomic classifier to determine whether it is DNA or RNA, ss or ds. The Galaxy Training Network offers workflows for viral genome assembly and annotation that can help you make this determination Galaxy Training Network.

  2. Predict the capsid symmetry. For well studied families, symmetry is known from literature. For novel viruses, use structural prediction tools or cryo EM data. The Bioconductor projects in structural biology provide R packages for analyzing protein structure data, including capsid models derived from X ray crystallography or electron microscopy Bioconductor.

  3. Check for an envelope. Sequence homology with known envelope proteins (e.g., spike glycoproteins) or identification of a matrix protein can indicate an enveloped virus. A recent field study of Usutu virus in wild birds used a lateral flow microarray immunoassay specifically targeting envelope proteins, demonstrating how envelope antigens are used in serological screening On-site serological screening of Usutu virus in wild birds: Field evaluation of a Lateral flow Microarray ImmunoAssay using the WHO REASSURED framework.

  4. Assess structural stability. Consider environmental factors and transmission routes. For non enveloped viruses, focus on capsid integrity assays. For enveloped viruses, examine the role of host membrane proteins and glycosylation sites.

Practical Workflow for Characterizing Virus Structure

This workflow assumes you have a viral sequence or a sample. Adapt the steps to your available data and tools.

Step 1: Acquire and Curate Sequence Data

Download raw sequencing reads from a repository such as the NCBI Sequence Read Archive NCBI Sequence Read Archive. Run quality control (FastQC) and trim adapters. For cultured virus isolates, you may have a purified genome sequence from Sanger or next generation sequencing.

Step 2: Genome Assembly and Annotation

Use a genome assembler appropriate for viral genomes (e.g., SPAdes, Unicycler for circular genomes). Annotate coding regions using Prokka or a viral specific database such as VFDB (virulence factors) or RVDB (virus reference database). The Galaxy Training Network provides step by step tutorials for viral genome annotation Galaxy Training Network.

Step 3: Identify Structural Components

  • Capsid proteins: Search for conserved domains using InterProScan or Pfam. Look for capsid protein families such as the jelly roll fold common in icosahedral viruses.
  • Envelope proteins: Detect transmembrane domains and signal peptides using TMHMM and SignalP. Align known glycoprotein sequences from related viruses.
  • Tegument (if large virus): In herpesviruses and giant viruses, look for multiple protein layers between capsid and envelope. The structural interactomics study of a giant virus identified dozens of proteins that form a complex inner membrane system Integrative structural interactomics reveals protein organization and structure in a giant virus.

Step 4: Predict 3D Structure (Optional but Powerful)

Use AlphaFold2 or RoseTTAFold for protein structure prediction. For capsid complexes, you may need multimer models. Validate models with Ramachandran plots or MolProbity. The Bioconductor package bio3d can help analyze structural dynamics and compare predicted models with experimentally determined structures Bioconductor.

Step 5: Validate with Experimental Data (If Available)

If you have cryo EM maps or X ray structures, dock your predicted models into the electron density using tools like ChimeraX or Phenix. Compare your computational predictions with published structures of related viruses. For example, a study on DENV 3 RdRp used computational docking and subsequent biological evaluation to confirm allosteric inhibitor binding, illustrating how prediction and experimental validation complement each other Computational discovery of DENV-3 RdRp allosteric inhibitors: biological evaluation and mechanistic studies.

Quality Checks

  • Check genome completeness. Use tools like QUAST or CheckV to assess assembly quality. Fragmented assemblies can lead to misidentification of structural genes.
  • Verify capsid symmetry assignments. Compare your predicted capsid protein fold with known structures in the Protein Data Bank. Use DALI or Foldseek for structural alignment.
  • Confirm envelope identification. Western blot or mass spectrometry can confirm presence of envelope proteins. In silico, check for predicted N glycosylation sites that are characteristic of many viral glycoproteins.
  • Cross reference with curated databases. The NCBI Bookshelf includes lists of virus families with known structural properties. Compare your results with taxon specific literature NCBI Bookshelf.

Common Mistakes

  • Assuming all viruses have a simple structure. Giant viruses (Mimivirus, Pandoravirus) have complex internal architectures that include multiple layers and even their own transcription machinery. Relying on a simple capsid envelope model can mislead your analysis of such viruses.
  • Ignoring the impact of the envelope on experimental methods. Enveloped viruses are disrupted by freeze thaw cycles, detergents, and alcohol based disinfectants. If you are performing structural studies, handling conditions must preserve the lipid bilayer.
  • Misclassifying a segmented genome. Some RNA viruses have multiple genome segments (e.g., influenza has 8 segments). Failure to assemble all segments can result in an incomplete structural picture.
  • Overinterpreting structural predictions from short sequences. Predicted structures of very short proteins (<50 amino acids) may be unreliable, their biological relevance should be confirmed with experimental data or literature.
  • Assuming symmetry from limited data. Negative stain electron microscopy of a few particles may not reveal the true symmetry. Use cryo EM with single particle analysis for robust assignments.

Limits of Interpretation

Structural models are hypotheses, not facts. Even high resolution cryo EM structures (2 3 angstroms) can contain errors in flexible loops or glycans. Computational predictions from AlphaFold2, while revolutionary, do not capture the effects of post translational modifications, pH, or interactions with host proteins. The influence of an envelope on transmission and drug susceptibility is context dependent. For instance, a recombinant GIIc subtype PEDV strain was shown to have a highly virulent phenotype that could not be predicted solely from its structural envelope proteins, virulence also depended on non structural genes and host factors Isolation and pathogenicity of a highly virulent recombinant GIIc subtype PEDV strain. Always interpret structural findings in the light of functional assays and epidemiological data.

Moreover, virus structure is not static. Many viruses undergo conformational changes during entry (e.g., hemagglutinin in influenza undergoes a low pH triggered rearrangement). Your model represents one snapshot, often the most stable in vitro state. The true dynamic nature of the viral particle requires integrative approaches combining structural biology, molecular dynamics, and single molecule techniques.

Frequently Asked Questions

1. Is the capsid always a perfect icosahedron?
No. Icosahedral symmetry is a design principle but real particles are imperfect. Some viruses have triangulation numbers (T numbers) that describe the number of capsid proteins per asymmetric unit. T=3, T=4, and T=7 are common, but deviations occur due to binding of genomic RNA or scaffolding proteins.

2. Can a virus have both DNA and RNA?
No. No known virus contains both DNA and RNA genomes. Some retroviruses have a reverse transcriptase that converts their RNA genome into DNA inside the host, but the virion itself only carries RNA.

3. How do we know if a virus is enveloped without a microscope?
Sequence analysis can hint at envelope proteins by identifying transmembrane domains, signal peptides, and homology to known envelope proteins. Sensitivity to ether or chloroform (lipid solvents) is a classic biochemical test for an envelope.

4. Are giant viruses structurally more complex than small viruses?
Yes. Giant viruses can have massive genomes (over 1 million base pairs) and complex capsid structures with internal membranes, fiber layers, and even a nucleus like compartment. Their structural interactomes are being mapped using integrative methods as shown in recent research Integrative structural interactomics reveals protein organization and structure in a giant virus.

References and Further Reading

Related Articles